Skip to main content
Premium Trial:

Request an Annual Quote

Takara Bio Gets CE-IVD Mark for SARS-CoV-2 Test

NEW YORK — Takara Bio Europe said on Tuesday that it has received CE-IVD marking for an RT-qPCR-based test for the detection of SARS-CoV-2.

The Takara SARS-CoV-2 Direct PCR detection kit is designed to detect regions of the SARS-CoV-2 nucleocapsid genes in nasopharyngeal or nasal swab samples, as well as crude saliva samples. It does not require RNA extraction and provides results within 60 minutes, the company said.

The test was approved in Japan last year, Takara Bio Europe said.

Takara Bio Europe is a French subsidiary of Japan's Takara Bio.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.